Management of Hypertension and Proteinuria after Treatment with Lenvatinib for Radioiodine Refractory Papillary Thyroid Carcinoma: a Case Report | Zendy

AI Assistant Blog Pricing

Open Access

Management of Hypertension and Proteinuria after Treatment with Lenvatinib for Radioiodine Refractory Papillary Thyroid Carcinoma: a Case Report

Author(s) -

Eyun Song,

Won Gu Kim

Publication year - 2018

Publication title -

international journal of thyroidology

Language(s) - English

Resource type - Journals

eISSN - 2466-1899

pISSN - 2384-3799

DOI - 10.11106/ijt.2018.11.2.78

Subject(s) - lenvatinib , medicine , adverse effect , thyroid carcinoma , refractory (planetary science) , proteinuria , oncology , thyroid , thyroid cancer , kidney , physics , astrobiology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.